Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |